Relapsed/refractory hodgkin lymphoma after first-line escalated beacopdac: adverse outcomes are overcome by use of second-line targeted therapy-an international real-world analysis
Jeffers, L. Santarsieri, A. Osborne, W. Chevillon, F. Vely, A. Bhartia, V. Collins, G. Barrett, A. Marzolini, M. George, L.
Jeffers, L.
Santarsieri, A.
Osborne, W.
Chevillon, F.
Vely, A.
Bhartia, V.
Collins, G.
Barrett, A.
Marzolini, M.
George, L.
Abstract
Authors
Description
Date
2025
Publisher
Collections
Keywords
Type
Article
Citation
Jeffers L, Santarsieri A, Osborne W, Chevillon F, Vely A, Bhartia V, et al. Relapsed/refractory hodgkin lymphoma after first-line escalated beacopdac: adverse outcomes are overcome by use of second-line targeted therapy-an international real-world analysis. Blood. 2025 NOV 3;146:3623-4.